Abstract Objective To investigate the effect of atopy on the expression of glucocorticoid receptors in children with bronchiolitis. Methods ELISA was used to measure the changes in the serum levels of glucocorticoid receptor α (GRα) and glucocorticoid receptor β (GRβ) in the bronchiolitis group (77 children, including 34 children with atopy) and pneumonia group (68 children). Thirty-eight children who were prepared to undergo surgeries for non-infectious diseases and had no atopy or family history of allergic diseases were enrolled as the control group. Results The bronchiolitis group and the pneumonia group had significant increases in the serum levels of GRα and GRβ compared with the control group (P < 0.01), and the bronchiolitis group had significant increases in these levels compared with the pneumonia group (P < 0.01). Compared with the control group and the pneumonia group, the bronchiolitis group had a significant increase in the GRα/GRβ ratio (P < 0.01). Compared with the control group, the children with or without atopy in the bronchiolitis group had significant increases in the serum levels of GRα and GRβ (P < 0.01). The non-atopic children in the bronchiolitis group had a significant increase in the serum level of GRβ compared with the atopic children (P < 0.01). The atopic children in the bronchiolitis group had a significant increase in the GRα/GRβ ratio compared with the control group and non-atopic children in the bronchiolitis group (P < 0.01). Conclusions Children with bronchiolitis have increased serum levels of GRα and GRβ. The children with atopy have an increased GRα/GRβ ratio, suggesting that the atopic children with bronchiolitis are highly sensitive to glucocorticoids.
YAO Huan-Yin,LIU Wei-Rong,ZHANG Hang-Hu et al. Effect of atopy on serum glucocorticoid receptor levels in children with bronchiolitis[J]. CJCP, 2017, 19(2): 163-166.
YAO Huan-Yin,LIU Wei-Rong,ZHANG Hang-Hu et al. Effect of atopy on serum glucocorticoid receptor levels in children with bronchiolitis[J]. CJCP, 2017, 19(2): 163-166.
McNaughten B,Bourke TW.Optimising the management of bronchiolitis in infants[J].Practitioner,2015,259(1784):13-15.
[2]
Ochoa Sangrador C,González de Dios J;Research Group of the aBREVIADo Project.Overuse of bronchodilators and steroids in bronchiolitis of different severity:bronchiolitisstudy of variability,appropriateness,and adequacy[J].Allergol Immunopathol (Madr),2014,42(4):307-315.
[3]
Tagarro A,Pérez L,Quintero VM,et al.Dexamethasone does not reduce length of hospitalization or recurrent wheezing 1 year after early bronchiolitis[J].Minerva Pediatr,2014,66(2):131-140.
[4]
Plint AC,Grenon R,Klassen TP,et al.Bronchodilator and steroid use for the management of bronchiolitis in Canadian pediatric emergency departments[J].CJEM,2015,17(1):46-53.
Relić T,Ilić N,Kostić G,et al.Respiratory syncytial virus infection and bronchial hyperreactivity in children up to two years of age in correlation with atopy[J].Vojnosanit Pregl,2016,73(1):59-65.
[9]
Wang W,Huang KW,Wu BM,et al.Correlation of eosinophil counts in induced sputum and fractional concentration of exhaled nitric oxide and lung functions in patients with mild to moderate asthma[J].Chin Med J (Engl),2012,125(17):3157-3160.
Fernandes RM,Hartling L.Glucocorticoids for acute viral bronchiolitis in infants and young children[J].JAMA,2014,311(1):87-88.
[12]
Barnes PJ.Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease[J].J Allergy Clin Immunol,2013,131(3):636-645.
[13]
Webster JI,Sternberg EM.Role of the hypothalamic-pituitaryadrenal axis,glucocorticoids and glucocorticoid receptors in toxic sequelae of exposure to bacterial and viral products[J].J Endocrinol,2004,181(2):207-221.
[14]
Diaz PV,Pinto RA,Mamani R,et al.Increased expression of the glucocorticoid receptor β in infants with RSV bronchiolitis[J].Pediatrics,2012,130(4):804-811.
Lewis-Tuffin LJ,Cidlowski JA.The physiology of human glucocorticoid receptor beta (hGR beta) and glucocorticoid resistance[J].Ann N Y Acad Sci,2006,1069:1-9.
